Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
NCT00515632
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
409
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Balaglitazone
Sponsor
Rheoscience A/S